
欧洲酶法 DNA 合成市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型(定制 DNA 合成和 DNA 库合成)、应用(合成生物学、基因工程、治疗性抗体、疫苗设计等)、技术( SOLA、CRISPR、PCR 等)和最终用户(学术和研究机构、生物技术和制药公司、诊断实验室等)
No. of Pages: 148 | Report Code: BMIRE00028390 | Category: Life Sciences
No. of Pages: 148 | Report Code: BMIRE00028390 | Category: Life Sciences
医疗技术的进步和制造商研发投资的增加导致了各种用于遗传和分子生物学研究的现代系统的推出。欧洲 DNA 酶合成市场的公司参与不同的产品开发活动。 2021年11月,OriCiro Genomics Inc.推出了OriCiro Cell-Free Switching系统。 2021年6月,DNA Script商业化推出了SYNTAX平台,并推出了首款产品——SYNTAX系统。该系统是第一台采用酶促 DNA 合成 (EDS) 技术的台式核酸打印机。 SYNTAX 系统是一款完全集成的自动化打印机,可并行合成 96 个 DNA 寡核苷酸,每个寡核苷酸的长度最多为 60 个核苷酸,并将它们交付用于分子生物学和基因组学工作流程,无需额外处理。 2021 年 1 月,Codex DNA, Inc. 与辉瑞签署了战略合作和许可协议,以获取并进一步开发 Codex DNA 的新型 EDS 技术,以实现其在辉瑞基于 mRNA 的疫苗和其他生物制药产品中的潜在应用。 >
此类发展可帮助最终用户满足对技术先进系统不断增长的需求,这些系统可以有效管理数据并提供准确的结果,从而促进欧洲酶 DNA 合成市场的增长。 p>
欧洲酶法 DNA 合成市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。该地区在 DNA 酶合成市场中占有重要的市场份额。由于遗传病患病率不断上升以及该地区疾病检测的有利举措等因素,预计该市场将在预测期内出现显着增长。
< p>
欧洲酶 DNA 合成市场细分为产品类型、应用、技术、最终用户和国家/地区。
根据产品类型,欧洲酶法 DNA 合成市场分为定制 DNA 合成和 DNA 文库合成。到2022年,DNA文库合成领域将在欧洲酶法DNA合成市场中占据更大份额。
根据应用,欧洲酶法DNA合成市场细分为合成生物学、基因工程、治疗性抗体、疫苗设计等。 2022年,合成生物学领域在欧洲DNA酶合成市场中占据最大份额。
根据技术,欧洲DNA酶合成市场分为SOLA、CRISPR、PCR , 和别的。到2022年,PCR细分市场在欧洲酶法DNA合成市场中占据最大份额。
根据最终用户,欧洲酶法DNA合成市场分为学术和商业领域。研究机构、生物技术和制药公司、诊断实验室等。 2022年,生物技术和制药公司细分市场在欧洲酶促DNA合成市场中占据最大份额
根据国家/地区,欧洲酶促DNA合成市场分为德国、英国、法国、意大利、西班牙和欧洲其他国家。 2022 年,德国在欧洲酶 DNA 合成市场份额中占据主导地位。
Camena Bio; DNA 脚本; Evonetix;金斯瑞生物科技公司;联生科技; Telesis生物公司;触摸灯;和 Twist Bioscience 是欧洲 DNA 酶合成市场的领先公司。
Strategic insights for Europe Enzymatic DNA Synthesis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 78.55 Million |
Market Size by 2028 | US$ 727.79 Million |
Global CAGR (2022 - 2028) | 44.9% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Enzymatic DNA Synthesis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Enzymatic DNA Synthesis Market is valued at US$ 78.55 Million in 2022, it is projected to reach US$ 727.79 Million by 2028.
As per our report Europe Enzymatic DNA Synthesis Market, the market size is valued at US$ 78.55 Million in 2022, projecting it to reach US$ 727.79 Million by 2028. This translates to a CAGR of approximately 44.9% during the forecast period.
The Europe Enzymatic DNA Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Enzymatic DNA Synthesis Market report:
The Europe Enzymatic DNA Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Enzymatic DNA Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Enzymatic DNA Synthesis Market value chain can benefit from the information contained in a comprehensive market report.